Patent details

300831 Product Name: Humane normale immunoglobuline

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300831
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2364730
Status:
Withdrawn
Application number:
300831
Procedural language:
Dutch
First Applicant Residence Country:
Switzerland (CH)

Marketing Authorization

Marketing Authorization Number:
EU/1/11/687/001-012
Marketing Authorization Type:
EEA
Marketing Authorization Date:
18/04/2011
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
22/09/2016
First Marketing Authorization date:
18/04/2011
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
28/09/2016
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
21/09/2020
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
28/09/2016
 
 

 

Name:
CSL Behring AG
Address:
Wankdorfstrasse 10, 3000 BERN 22, Switzerland (CH)

Agent

Name:
ir. F.A. Geurts c.s.
From:
28/09/2016
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
39/20
Publication date:
23/09/2020
Description:
Lapse or annulment

2

Bulletin Heading:
SPC
Journal edition number:
39/16
Publication date:
28/09/2016
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date Document type Document Description Number of pages File Type
22/09/2020 Outgoing Correspondence Letter confirmation withdrawal 1 PDF /5/1/9/1/9/0800091915/docs/300831_7_367777l193.pdf
21/09/2020 SPC Documents Withdrawal SPC 1 PDF /5/1/9/1/9/0800091915/docs/300831_1_supplprotectioncertificate20200921033205022.pdf
29/07/2020 Outgoing Correspondence Letter to applicant 2 PDF /5/1/9/1/9/0800091915/docs/300831_2_357077l173.pdf
29/09/2016 Outgoing Correspondence Confirmation receipt request 1 PDF /5/1/9/1/9/0800091915/docs/300831_8_87228l174.pdf
22/09/2016 SPC Documents Accompanying letter SPC 1 PDF /5/1/9/1/9/0800091915/docs/300831_0_supplprotectioncertificate20210406020424269.pdf
22/09/2016 SPC Documents Annex SPC 1 PDF /5/1/9/1/9/0800091915/docs/300831_3_supplprotectioncertificate20200420014748114.pdf
22/09/2016 Application Form First filed application form 3 PDF /5/1/9/1/9/0800091915/docs/300831_4_applicationform20160927045136157.pdf
22/09/2016 SPC Documents Marketing Authorization SPC 4 PDF /5/1/9/1/9/0800091915/docs/300831_5_supplprotectioncertificate20160927045136498.pdf
22/09/2016 SPC Documents Summary of the characteristics of the product 9 PDF /5/1/9/1/9/0800091915/docs/300831_6_supplprotectioncertificate20160927045136575.pdf